Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Carnival Corporation reported record third-quarter 2026 financial results, including all-time high net income of $1.9 billion and record revenues. The company outperformed its previous guidance by $110 million in Adjusted EBITDA and noted that 2027 bookings are already at record occupancy and pricing levels.
Term
Q3 2026
Earnings call
Sep 29, 2026, 10:00 AM ET
“We delivered another quarter of top and bottom-line records, with accelerating demand and even stronger cost discipline driving results ahead of our expectations. This performance reinforces the underlying trajectory of our business and the consistency of our commercial execution, as evidenced by our sustained track record of high-quality same-ship yield growth.”
“Our booking trends continued to strengthen throughout the quarter, with volumes meaningfully ahead of last year and far outpacing capacity growth. This momentum underscores the effectiveness of our demand generation efforts and the enduring appeal of our cruise lines.”
Liminatus Pharma has regained compliance with Nasdaq's minimum bid price requirement after its common stock maintained a closing bid price above $1.00 for 13 consecutive trading days. The company previously effected a 1-for-50 reverse stock split on August 20, 2026, to address the deficiency. Nasdaq has officially closed the matter, and the company remains listed on The Nasdaq Capital Market.
Cohen & Steers Income Opportunities REIT M&A Deal with Grand Canyon Crossing Shopping Center
Cohen & Steers Income Opportunities REIT (CNSREIT) has acquired Grand Canyon Crossing, a 99%-occupied shopping center in Phoenix, Arizona, anchored by a high-performing Walmart Supercenter. The acquisition was made through a programmatic joint venture with the Sterling Organization. The deal aligns with CNSREIT's strategy of investing in income-generating retail assets anchored by necessity-based tenants in high-growth markets.
uniQure N.V. released a clinical program update for AMT-130 (ifezuntirgene inilparvovec), its gene therapy candidate for Huntington’s disease. The update includes long-term data from ongoing Phase I/II clinical trials and details regarding the enrollment of a fourth cohort. The company is also evaluating neurofilament light chain (NfL) in cerebrospinal fluid as a potential biomarker for disease severity.
ONAR Holding Corporation entered into a securities purchase agreement for up to $15 million in secured convertible promissory notes, with an initial closing of approximately $3.94 million. Additionally, the company exchanged $6.38 million of existing indebtedness for $7.09 million in new exchange notes to align its debt structure with its Nasdaq listing strategy. The proceeds are intended to fund the cash consideration for a previously announced acquisition of a U.S. affiliate marketing agency.
Capstone Holding Corp. has retired approximately 85% of its original $6.82 million convertible note principal, reducing the remaining balance to $1 million. The reduction was achieved through the conversion of notes into 2,446,825 shares of common stock, effectively fully retiring the July 2025 note and leaving only the October 2025 note outstanding.
Federal Home Loan Bank of Indianapolis Executive Compensation
The Federal Home Loan Bank of Indianapolis appointed Chad A. Brandt as Executive Vice President - Chief Financial Officer, effective September 1, 2026. Mr. Brandt will receive an annual base salary of $480,000 and remains a participant in the Bank's 2026 Incentive Compensation Plan. The filing also details several other senior leadership promotions and organizational changes across risk, banking, and technology functions.
TMC the metals company Inc. appointed Liam Mallon, the former President of ExxonMobil Upstream Company, to its Board of Directors effective September 24, 2026. Mr. Mallon fills the vacancy created by the resignation of Brendan May and will serve as Chair of the Sustainability and Innovation Committee. The appointment adds significant global energy and offshore operating experience to the board as the company prepares for commercial-scale deep seabed mineral operations.
Moleculin Biotech has completed and closed enrollment for Part A of its pivotal Phase 2/3 MIRACLE trial evaluating Annamycin in combination with cytarabine (AnnAraC) for relapsed or refractory acute myeloid leukemia (R/R AML). The company enrolled 89 subjects and remains on track for a comprehensive data readout in the first quarter of 2027. The final Part A dataset is expected to provide efficacy insights across both 'fit' and 'unfit' patient populations, with an estimated 50/50 split between those previously treated with intensive chemotherapy versus venetoclax-based regimens.
Omniq Wins Contract from Two Pennsylvania municipalities
OMNIQ Corp. secured its first deployments in Pennsylvania through two-year agreements with two municipalities to implement its Q Shield™ Safe City platform for vehicle registration enforcement. The projects involve 18 cameras across nine intersections and utilize a citation-based processing fee model, creating a transaction-based recurring revenue stream for the company.
Counterparty
Two Pennsylvania municipalities (a borough and a township)
Global Business Travel Group Signs $6.3B M&A Deal with Long Lake Management
Global Business Travel Group (Amex GBT) completed its acquisition by Long Lake Management in an all-cash transaction valuing the company at approximately $6.3 billion. As a result of the merger, Amex GBT has become a privately held company and its Class A common stock will be delisted from the NYSE. The transaction was financed through a combination of equity from Long Lake investors and Koch Equity Development, along with a new $1.5 billion senior secured term loan facility.
Jess Lipsey resigned as CEO, President, and Director of Apollo Realty Income Solutions effective September 30, 2026, to pursue other opportunities. The company appointed Bert Crouch, a Partner at Apollo and head of its real estate equity franchise, to succeed Lipsey in all three roles.
CareCloud, Inc. has appointed Bonnie Boyer as Chief Financial Officer, effective October 1, 2026, succeeding Norman Roth who will transition to Advisor to the CEO. Ms. Boyer, who previously served as Assistant CFO, entered into an employment agreement with a $300,000 base salary and a 30% target bonus. The transition occurs as the company focuses on accelerating growth for its AI-powered healthcare technology platform.
Host Digital issued a shareholder letter following its recent merger and public listing to outline its strategy as a vertically integrated digital infrastructure company. The company focuses on 'RightScaled' data centers (20-100 megawatts) for AI and HPC workloads, with a pipeline of four additional sites totaling over 450 megawatts of potential capacity targeted for delivery by the end of 2027.
Nauticus Robotics Debt Financing Update with Holder of Series C Convertible Preferred Stock
Nauticus Robotics received a waiver from a Series C Preferred Stock holder regarding a 'Triggering Event' that would have occurred if shares remained outstanding after September 30, 2026. The waiver extends the deadline to December 31, 2027, preventing a dividend rate increase to 18% and a 25% conversion premium. This provides the company with significant financial relief and additional time to address its preferred stock obligations without incurring default-related penalties.
Ensysce Biosciences filed an amendment to its Series C Non-Voting Convertible Preferred Stock certificate of designation to remove a cash redemption option. Previously, Section 6.5.3 allowed holders to redeem shares for cash if the company failed to deliver common stock upon conversion; this provision has now been eliminated.
OneMedNet Corporation is implementing a 1-for-10 reverse stock split of its common stock, effective September 29, 2026. The action is intended to bring the company into compliance with Nasdaq's minimum bid price requirement for continued listing. The split will reduce the outstanding share count from approximately 60.1 million to approximately 6.0 million shares.
PRA Group, Inc. announced a private offering of $400 million in senior notes due 2033. The company intends to use the net proceeds and available cash to repay approximately $400 million of outstanding borrowings under its North American revolving credit facility.
The PNC Financial Services Group announced it will redeem all $525 million of its outstanding Depositary Shares representing interests in its Series S Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock. The redemption is scheduled for November 2, 2026, at a price of $1,000 per Depositary Share plus any declared but unpaid dividends.
NewAmsterdam Pharma has dosed the first participant in its Phase 2b SPINOZA clinical trial, which evaluates obicetrapib in approximately 400 individuals with preclinical Alzheimer’s disease. The study will assess changes in blood-based biomarkers and cognitive measures over a 52-week treatment period. This expansion into Alzheimer's follows biomarker signals observed in the company's Phase 3 BROADWAY trial.
Flash Sports & Media Holdings Wins $506K Contract from MindWave Innovations Inc.
Flash Sports & Media Holdings entered into a software development and technology services agreement with MindWave Innovations to build and operate 'FlashChain,' a dedicated blockchain network for sports media and ticketing. As consideration, the company will issue $506,000 in common stock and 20% of its FLASH TOKEN supply to MindWave. The partnership aims to authenticate digital broadcasting rights, video assets, and match-ticket inventory while preventing counterfeiting.
Alaska Air Group hosted its 2026 Investor Day in Seattle to outline the 'activation phase' of its Alaska Accelerate strategic plan following the acquisition of Hawaiian Airlines. The company announced targets for $1 billion in incremental profit by 2027 and plans to expand its network to at least 15 intercontinental destinations from Seattle by 2030. The event included the filing of a formal Investor Day presentation and multiple press releases detailing new premium products, loyalty program growth, and fleet expansion.
Ford Motor Credit Company LLC completed the issuance and sale of €750 million aggregate principal amount of 4.645% Notes due October 29, 2029. The notes were issued under the company's existing Euro Medium-Term Note program and registered under its effective S-3 registration statement.
Keros Therapeutics Licensing Deal with Takeda Pharmaceuticals U.S.A., Inc. Worth $20M
Keros Therapeutics announced it will receive a $20 million development milestone payment from its partner Takeda following the dosing of the first patient in the Phase 3 ELRiSE MF clinical trial for elritercept. The payment is part of a global license agreement that includes potential milestones exceeding $1.1 billion. Keros intends to distribute 25% of the net cash proceeds from this milestone to its stockholders.
Allarity Therapeutics has expanded its in-house medical laboratory capabilities to include proteomics and cell line research. These new capabilities will support deeper mechanism-of-action research for its lead asset, stenoparib, and allow the company to offer a broader range of research services to external partners. The expansion is expected to create cost efficiencies without impacting the company's current cash runway.
Imunon $1.2M Debt Financing with Streeterville Capital, LLC
Imunon, Inc. entered into an exchange agreement with Streeterville Capital, LLC to exchange $1.2 million of the principal amount of an existing Secured Promissory Note (A-1 Note) for 120 shares of newly designated Series B Preferred Stock. This transaction reduces the company's outstanding debt obligations under the A-1 Note by the amount exchanged, while the Series B Preferred Stock will carry an 8% annual return and a stated value of $12,000 per share.
TOP Financial Group Limited entered into amended appointment letters with its three independent non-executive directors to restructure their compensation. Effective October 1, 2026, the $20,000 annual share-based compensation component for each director will be replaced by an equivalent cash payment, bringing their total annual cash compensation to $50,000 each.
First United Corporation elected Steven R. Stuck, Shawn Bender, and Nina Beitzel to its Board of Directors, effective September 24, 2026. The new directors will serve until the 2027 annual meeting and have been appointed to various committees including Audit, Risk and Compliance, and Loan. The appointments bring expertise from the energy, industrial services, and real estate sectors to the board.
Bloomin' Brands $1.2B Debt Financing with Wells Fargo Bank, National Association
Bloomin’ Brands entered into a Fourth Amended and Restated Credit Agreement to extend the maturity of its $1.2 billion revolving credit facility to September 25, 2031. The refinancing maintains existing interest rate spreads and liquidity while adding a new consolidated senior secured net leverage ratio covenant of 3.50 to 1.00.
SurgePays received an additional 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement, extending the deadline to March 22, 2027. Separately, Nasdaq confirmed the company has regained compliance with the minimum stockholders' equity requirement. The company intends to cure the bid price deficiency by effecting a reverse stock split if necessary.